4.3 Article

Fibroblasts Impair Migration and Antitumor Activity of NK-92 Lymphocytes in a Melanoma-on-Chip Model

Related references

Note: Only part of the references are listed.
Review Cell & Tissue Engineering

CAR T cells in solid tumors: challenges and opportunities

Faroogh Marofi et al.

Summary: CAR T cells have shown significant advancements in treating blood disorders, but face challenges in solid tumor therapy due to issues with recognition, trafficking, and survival within the tumor. Efforts to overcome these challenges, including addressing the immunosuppressive tumor microenvironment, show promise in reducing T cell exhaustion and improving therapeutic outcomes in non-hematologic malignancies.

STEM CELL RESEARCH & THERAPY (2021)

Review Oncology

The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy

Kellsye P. Fabian et al.

Summary: This review outlines the importance of NK cells in cancer treatment and the development of NK-92 cell line in CAR-engineering, demonstrating robust antitumor activity and potential as a next-generation off-the-shelf cell therapy platform.

MOLECULAR THERAPY-ONCOLYTICS (2021)

Article Oncology

Recruitment, Infiltration, and Cytotoxicity of HLA-Independent Killer Lymphocytes in Three-Dimensional Melanoma Models

Ilenia Iaia et al.

Summary: The 3D immune effector model for melanoma demonstrates that Cytokine-Induced Killer (CIK) and NK-92 cells can effectively recruit, infiltrate, and kill tumors, shedding light on the role and kinetics of immune effectors in solid tumors.

CANCERS (2021)

Review Oncology

3D Cancer Models: Depicting Cellular Crosstalk within the Tumour Microenvironment

Teresa Franchi-Mendes et al.

Summary: The tumour microenvironment consists of multiple non-cancerous cells that interact with tumour cells, influencing disease progression and therapeutic responses. In vitro 3D models have been developed to mimic the complexity of the tumour microenvironment, providing insights for cancer research and drug discovery. Understanding the role of each cell type in the microenvironment is crucial for uncovering potential therapeutic targets.

CANCERS (2021)

Review Oncology

Three-Dimensional Culture Models to Study Innate Anti-Tumor Immune Response: Advantages and Disadvantages

Alessandro Poggi et al.

Summary: Studying immune responses against tumors is crucial, and traditional experimental settings using immune cells mixed with tumor cells may not fully represent human conditions. Alternative culture methods and three-dimensional culture systems have been developed to better mimic human situations and investigate NK cell interactions with tumor cells.

CANCERS (2021)

Review Nanoscience & Nanotechnology

Tumor-on-a-chip: from bioinspired design to biomedical application

Xingxing Liu et al.

Summary: Tumor-on-a-chip devices provide a promising platform for mimicking the complex tumor microenvironment and have the potential to bridge the gap between basic research and clinical applications in cancer biology and therapy. These emerging platforms, integrating 3D cell culture, microfluidic technology, and tissue engineering, offer new insights into the mechanisms of tumor evolution, drug screening, and cancer treatment development.

MICROSYSTEMS & NANOENGINEERING (2021)

Review Pharmacology & Pharmacy

CAR T-Cell Therapy in Hematologic Malignancies: A Voyage in Progress

Sarah A. Holstein et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)

Review Cell Biology

Crosstalk between cancer-associated fibroblasts and immune cells in cancer

Yuanyuan An et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

Review Engineering, Biomedical

Could 3D models of cancer enhance drug screening?

Virginia Brancato et al.

BIOMATERIALS (2020)

Review Oncology

3D models in the new era of immune oncology: focus on T cells, CAF and ECM

Francesca Di Modugno et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Review Oncology

The Emerging World of TCR-T Cell Trials Against Cancer: A Systematic Review

Jianxiang Zhang et al.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2019)

Article Engineering, Biomedical

Evaluating CAR-T Cell Therapy in a Hypoxic 3D Tumor Model

Yuta Ando et al.

ADVANCED HEALTHCARE MATERIALS (2019)

Review Oncology

Cancer-associated fibroblasts-heroes or villains?

Krystyna A. Gieniec et al.

BRITISH JOURNAL OF CANCER (2019)

Review Pathology

Adoptive cellular therapies: the current landscape

Maartje W. Rohaan et al.

VIRCHOWS ARCHIV (2019)

Review Biochemistry & Molecular Biology

CAR T-cell Therapy: A New Era in Cancer Immunotherapy

Miliotou N. Androulla et al.

CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2018)

Review Immunology

Alteration of the Antitumor immune Response by Cancer-Associated Fibroblasts

Linda Ziani et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Nanoscience & Nanotechnology

Optimized design and fabrication of a microfluidic platform to study single cells and multicellular aggregates in 3D

S. L. Marasso et al.

MICROFLUIDICS AND NANOFLUIDICS (2017)

Review Oncology

Trial Watch: Adoptively transferred cells for anticancer immunotherapy

Carole Fournier et al.

ONCOIMMUNOLOGY (2017)

Review Oncology

Adoptive Cell Therapy for Metastatic Melanoma

Efrat Merhavi-Shoham et al.

CANCER JOURNAL (2017)

Review Oncology

Trial Watch: Adoptive cell transfer for oncological indications

Fernando Aranda et al.

ONCOIMMUNOLOGY (2015)

Review Oncology

Immune-suppressive properties of the tumor microenvironment

Juergen C. Becker et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)

Article Oncology

Melanoma as a model tumour for immuno-oncology

M. Maio

ANNALS OF ONCOLOGY (2012)

Review Oncology

Hallmarks of cancer: Interactions with the tumor stroma

Kristian Pietras et al.

EXPERIMENTAL CELL RESEARCH (2010)

Review Oncology

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

Steven A. Rosenberg et al.

NATURE REVIEWS CANCER (2008)

Article Immunology

Cutting edge: Down-regulation of MICA on human tumors by proteolytic shedding

HR Salih et al.

JOURNAL OF IMMUNOLOGY (2002)